Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma

Nat Clin Pract Oncol. 2008 Jul;5(7):374-5. doi: 10.1038/ncponc1151. Epub 2008 Jun 10.

Authors

Nikhil C Munshi¹, Constantine Mitsiades, Paul G Richardson, Kenneth C Anderson

Affiliation

¹ Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA. nikhil_munshi@dfci.harvard.edu

PMID: 18542118
DOI: 10.1038/ncponc1151

No abstract available

Publication types

Comment